Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Larry Biegelsen
WF
Larry Biegelsen
Wall Street Analyst
★★☆☆☆
#1875
on 13Foresight · ranked by our own returns
42%
Success Rate
-3.7%
Average Return
23 of 55 calls profitable · -8.5% vs benchmark
📈 Across the calls we could measure, roughly 42% of Larry Biegelsen's ratings turned a profit when each position was held for 2 year — averaging -3.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

125 Buy 65 Hold 0 Sell
Larry's Stock Coverage 42 ratings · 2026-06-20
Company Date Position Consensus Price Target 2-Yr Return
ABT
Abbott Laboratories
Jun 15, 2026 BUY Strong Buy
+31.2% avg upside
35 analysts
$109.00
23.29% Upside
-0.2%
AVR
Anteris Technologies Global Corp.
Jun 15, 2026 BUY Strong Buy
+49.3% avg upside
5 analysts
$16.00
63.55% Upside
·
MDT
Medtronic
Jun 15, 2026 BUY Buy
+23.5% avg upside
38 analysts
$102.00
28.64% Upside
-1.3%
PEN
Penumbra
Jun 12, 2026 HOLD Buy
+4.4% avg upside
23 analysts
$374.00
17.83% Upside
-0.8%
DXCM
Dexcom
Jun 10, 2026 BUY Strong Buy
+38.6% avg upside
32 analysts
$85.00
17.30% Upside
-2.1%
PODD
Insulet
Jun 08, 2026 BUY Strong Buy
+79.0% avg upside
32 analysts
$255.00
74.89% Upside
-1.2%
MMED
MiniMed Group, Inc.
Jun 08, 2026 BUY Strong Buy
+47.2% avg upside
13 analysts
$26.00
76.04% Upside
·
GKOS
Glaukos
Jun 05, 2026 BUY Strong Buy
+5.5% avg upside
20 analysts
$138.00
5.55% Upside
·
COO
Cooper Co
Jun 05, 2026 HOLD Buy
+102.3% avg upside
21 analysts
$66.00
0.11% Upside
+0.0%
TNDM
Tandem Diabetes Care
Jun 01, 2026 BUY Buy
+116.0% avg upside
29 analysts
$27.00
76.41% Upside
-11.6%
ZBH
Zimmer Biomet Holdings
Jun 01, 2026 HOLD Buy
+27.6% avg upside
37 analysts
$90.00
2.34% Upside
+7.0%
BSX
Boston Scientific
May 28, 2026 HOLD Strong Buy
+72.9% avg upside
38 analysts
$55.00
21.36% Upside
-7.7%
ISRG
Intuitive Surgical
May 28, 2026 BUY Strong Buy
+29.4% avg upside
36 analysts
$654.00
60.82% Upside
-4.0%
NPCE
NeuroPace
May 27, 2026 BUY Strong Buy
+12.2% avg upside
11 analysts
$19.00
21.63% Upside
-11.1%
SOLV
Solventum Corporation
May 22, 2026 HOLD Buy
+14.1% avg upside
15 analysts
$70.00
7.25% Downside
-2.9%
HTFL
HeartFlow, Inc.
May 15, 2026 BUY Strong Buy
+9.2% avg upside
8 analysts
$37.00
10.04% Upside
+8.3%
ENOV
Enovis
May 08, 2026 BUY Strong Buy
+216.5% avg upside
37 analysts
$40.00
82.04% Upside
-6.2%
GMED
Globus Medical
May 08, 2026 BUY Strong Buy
+21.0% avg upside
24 analysts
$103.00
30.02% Upside
+3.1%
TFX
Teleflex
May 08, 2026 HOLD Buy
+42.1% avg upside
19 analysts
$138.00
8.72% Upside
-4.3%
IART
Integra Lifesciences
May 06, 2026 HOLD Buy
+136.2% avg upside
21 analysts
$15.00
14.73% Downside
+22.9%
INSP
Inspire Medical Systems
May 05, 2026 HOLD Buy
+97.6% avg upside
20 analysts
$56.00
31.50% Upside
-12.4%
NVCR
NovoCure
May 04, 2026 HOLD Strong Buy
+242.4% avg upside
11 analysts
$17.00
18.99% Upside
+3.8%
SYK
Stryker
May 01, 2026 BUY Strong Buy
+24.0% avg upside
36 analysts
$418.00
35.82% Upside
+3.0%
MMSI
Merit Medical Systems
May 01, 2026 HOLD Strong Buy
+35.1% avg upside
15 analysts
$74.00
10.12% Upside
+0.9%
AXGN
AxoGen
Apr 29, 2026 BUY Strong Buy
-25.7% avg upside
21 analysts
$48.00
7.05% Upside
+6.7%
JNJ
Johnson & Johnson
Apr 15, 2026 BUY Strong Buy
-3.5% avg upside
36 analysts
$263.00
15.10% Upside
-3.8%
ATEC
Alphatec Holdings
Mar 17, 2026 BUY Strong Buy
+112.9% avg upside
22 analysts
$28.00
217.76% Upside
-38.0%
CNMD
Conmed
Mar 17, 2026 HOLD Hold
+81.2% avg upside
12 analysts
$42.00
28.90% Upside
-2.7%
CH:ALC
Alcon
Feb 26, 2026 BUY Buy
+33.9% avg upside
35 analysts
$76.87
45.36% Upside
·
ITGR
Integer Holdings
Feb 20, 2026 HOLD Buy
+6.0% avg upside
15 analysts
$84.00
7.60% Downside
+6.6%
BLCO
Bausch + Lomb Corporation
Feb 19, 2026 HOLD Buy
+30.8% avg upside
19 analysts
$18.00
21.14% Upside
-14.0%
EW
Edwards Lifesciences
Feb 11, 2026 BUY Strong Buy
+11.7% avg upside
34 analysts
$100.00
14.45% Upside
+9.3%
BDX
Becton Dickinson
Feb 10, 2026 HOLD Buy
+35.5% avg upside
25 analysts
$157.00
8.99% Upside
-15.0%
GEHC
GE Healthcare Technologies Inc
Feb 05, 2026 BUY Strong Buy
+36.0% avg upside
20 analysts
$97.00
57.54% Upside
-25.1%
RMD
Resmed
Jan 30, 2026 HOLD Buy
+25.4% avg upside
27 analysts
$270.00
43.20% Upside
-24.8%
KMTS
Kestra Medical Technologies Ltd.
Jan 14, 2026 BUY Strong Buy
+37.1% avg upside
7 analysts
$28.00
40.57% Upside
-7.5%
RXST
RxSight
Dec 12, 2025 HOLD Hold
+132.6% avg upside
13 analysts
$13.00
174.94% Upside
-52.5%
BAX
Baxter International
Dec 12, 2025 HOLD Hold
+49.6% avg upside
23 analysts
$19.00
4.52% Downside
+8.8%
LUNG
Pulmonx
Nov 13, 2025 HOLD Buy
+321.4% avg upside
9 analysts
$3.00
134.39% Upside
-13.8%
HYPR
Hyperfine
Oct 21, 2025 HOLD Strong Buy
+27.5% avg upside
6 analysts
+20.3%
LNTH
Lantheus
Aug 02, 2018 BUY Strong Buy
-27.9% avg upside
20 analysts
$20.00
80.80% Downside
+1.0%
NVS
Novartis
Jan 04, 2010 BUY Hold
-7.5% avg upside
24 analysts
+19.1%
🔒 37 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Larry Biegelsen — Frequently Asked Questions
How accurate are Larry Biegelsen's stock ratings?
Based on the calls 13Foresight could measure, about 42% of Larry's ratings were profitable over a one-year hold, with an average return of -2.1% per rating, or -6.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Larry ranked on 13Foresight?
Larry Biegelsen is currently ranked #1875 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Larry cover?
Larry most recently has ratings on ABT, AVR, MDT, PEN, DXCM, PODD, MMED, GKOS, COO, TNDM, ZBH, BSX and 30 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.